Global Cell Banking Outsourcing Market

Cell Banking Outsourcing Market Size, Share, Growth Analysis, By Type (Master Cell Banking, Viral Cell Banking), By Product (Cord Cell Banking, Adult Stem Cell Banking), By Cell Type (Stem Cell, Non-Stem Cell), By Phase, By Region - Industry Forecast 2026-2033

Report ID: SQMIG35D2076 | Region: Global | Published Date: December, 2025
Pages: 219 |Tables: 59 |Figures: 75

To request a free sample copy of this report, please complete the form below.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Cell Banking Outsourcing Market size was valued at USD 15.59 Billion in 2024 and is poised to grow from USD 18.27 Billion in 2025 to USD 65.04 Billion by 2033, growing at a CAGR of 17.2% during the forecast period (2026–2033). 

    The global cell banking outsourcing market is highly competitive and fragmented, with several small and large players offering a wide range of services. The market players compete based on factors such as service quality, pricing, technology, and customer service. The presence of favorable government initiatives, collaborations, and strategic partnerships are also significant competitive factors in the market. Moreover, market players are focusing on the development of new technologies and services to meet the increasing demand for cell banking services. The intense competition in the market is expected to drive innovation and foster growth in the industry. 'Charles River Laboratories (USA) ', 'Lonza (Switzerland) ', 'Merck KGaA (Germany) ', 'SGS Société Générale de Surveillance SA (Switzerland) ', 'Cryo-Cell International, Inc. (USA) ', 'LifeCell (India) ', 'WuXi AppTec (China) ', 'Eurofins Scientific (Luxembourg) ', 'Sartorius (Bio Outsource) (Germany) ', 'BSL Bioservice (Germany) ', 'ViaCord (USA) ', 'StemCyte, Inc. (USA) ', 'Cryoviva Biotech Pvt. Ltd. (India) '

    One of the major drivers of the global cell banking outsourcing market is the increasing adoption of stem cell therapies. Stem cell therapy is a rapidly growing field of regenerative medicine that has the potential to treat a wide range of diseases and disorders. As the demand for stem cell therapies grows, the need for stable and high-quality cell lines increases, leading to a greater demand for cell banking services. This is driving the growth of the cell banking outsourcing market, as biopharmaceutical companies and CROs seek efficient and cost-effective solutions for producing and storing these valuable cell lines.

    One key trend in the cell banking outsourcing market is the increasing demand for personalized medicine. Personalized medicine aims to provide individualized treatment based on a patient's genetic makeup. This requires the use of cells that are tailored to the specific needs of the patient. Cell banking outsourcing companies are investing in technologies that allow them to produce cells that are genetically matched to the patient. This trend is expected to drive the growth of the market as the demand for personalized medicine continues to increase.

    North America dominated the market due to the presence of a well-established biopharmaceutical industry and advanced healthcare infrastructure. The growing demand for personalized medicines and increasing research activities in the region are driving the growth of the cell banking outsourcing market. The United States is the largest contributor to the growth of the North American market due to the increasing investments in the research and development of cell-based therapies.

    Related Reports

    Mobile Banking Market
    Buy Now GET FREE SAMPLE
    Biotechnology & Pharmaceutical Services Outsourcing Market
    Buy Now GET FREE SAMPLE
    Medical Device Outsourcing Market
    Buy Now GET FREE SAMPLE
    Third-Party Banking Software Market
    Buy Now GET FREE SAMPLE
    Digital Banking Market
    Buy Now GET FREE SAMPLE
    Retail Banking Market
    Buy Now GET FREE SAMPLE
    Biobanking Market
    Buy Now GET FREE SAMPLE
    Regulatory Affairs Outsourcing Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Cell Banking Outsourcing Market

    Report ID: SQMIG35D2076

    $5,300
    BUY NOW